Trials / Conditions / Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
7 registered clinical trials studyying Eosinophilic Granulomatosis With Polyangiitis (EGPA) — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and NCT07444567 | AstraZeneca | Phase 3 |
| Recruiting | A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases NCT06512883 | AstraZeneca | Phase 3 |
| Not Yet Recruiting | Eosinophil Subpopulations in Eosinophilic-associated Diseases NCT06911775 | University of Florence | — |
| Completed | Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis NCT03482479 | University of Pennsylvania | Phase 2 |
| Recruiting | Clinical Transcriptomics in Systemic Vasculitis (CUTIS) NCT03004326 | Peter Merkel | — |
| Completed | Rituximab in Eosinophilic Granulomatosis With Polyangiitis NCT02807103 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Recruiting | Vasculitis Pregnancy Registry NCT02593565 | University of Pennsylvania | — |